MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes - Mayr, C.; Bund, D.; Schlee, M.; Bamberger, M.; Kofler, D.M.; Hallek, M.; Wendtner, C.-M. (Experimental Hematology, 2006)